Lexaria Bioscience (LEXX) Operating Income (2017 - 2025)
Historic Operating Income for Lexaria Bioscience (LEXX) over the last 12 years, with Q4 2025 value amounting to -$1.6 million.
- Lexaria Bioscience's Operating Income rose 4151.61% to -$1.6 million in Q4 2025 from the same period last year, while for Nov 2025 it was -$10.8 million, marking a year-over-year decrease of 4735.26%. This contributed to the annual value of -$11.9 million for FY2025, which is 10650.91% down from last year.
- Latest data reveals that Lexaria Bioscience reported Operating Income of -$1.6 million as of Q4 2025, which was up 4151.61% from -$2.7 million recorded in Q3 2025.
- Lexaria Bioscience's Operating Income's 5-year high stood at -$668005.0 during Q1 2024, with a 5-year trough of -$3.8 million in Q2 2025.
- Its 5-year average for Operating Income is -$1.9 million, with a median of -$1.7 million in 2024.
- As far as peak fluctuations go, Lexaria Bioscience's Operating Income soared by 4953.22% in 2024, and later plummeted by 31182.51% in 2025.
- Over the past 5 years, Lexaria Bioscience's Operating Income (Quarter) stood at -$2.0 million in 2021, then grew by 15.38% to -$1.7 million in 2022, then skyrocketed by 32.81% to -$1.1 million in 2023, then plummeted by 136.2% to -$2.7 million in 2024, then surged by 41.52% to -$1.6 million in 2025.
- Its Operating Income stands at -$1.6 million for Q4 2025, versus -$2.7 million for Q3 2025 and -$3.8 million for Q2 2025.